Should I Buy AZN Stock in 2026?
Data-driven analysis and honest assessment for AstraZeneca PLC
Current Price: $0.00P/E: 28.0
Decision Score
Hold
Based on 6 fundamental factors
Score Breakdown:
Elevated P/E of 28.0
Growth data limited
Profitability data limited
Financial health data limited
Cash flow data limited
No recent insider activity
Key Investment Metrics
Current Price
$0.00
P/E Ratio
28.00
Revenue Growth
N/A
Profit Margin
N/A
Market Cap
$288.4B
Dividend Yield
1.76%
How AZN Compares to Competitors
Understanding how AZN stacks up against peers helps inform your investment decision.
How AZN Compares to Peers
Upcoming Events for AZN
+5 Reasons TO Buy AZN
1. Large-cap stability and market leadership
moderateWith market cap over $100B, this company has established leadership and resources to weather cycles.
-5 Reasons NOT to Buy AZN
1. Minimal revenue growth
low riskGrowth of 0.0% barely keeps pace with inflation.
Who Should Buy AZN?
Investment Profile
Risk Level
Medium
Recommended Holding Period
3-5 years
Best For:
Not Suitable For:
- ✗
Growth Investors
Limited 0% growth may disappoint
- ✗
Income-Focused Retirees
Low 1.8% yield
Consider These Alternatives
If you're interested in AZN, compare these Healthcare peers:
Pro tip: Compare AZN directly with competitors using our comparison tool to see which stock better fits your criteria.
Get the Full Picture
Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for AZN
Frequently Asked Questions
What is AZN stock price today?
Visit our real-time dashboard for the current AZN stock price and live market data.
Is AZN stock going up or down today?
AZN stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy AZN stock now?
The decision to buy AZN depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is AZN a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for AZN based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is AZN stock overvalued or undervalued?
AZN currently trades at a P/E ratio of 28.00, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if AZN is fairly priced.
What is AZN's P/E ratio?
AZN has a price-to-earnings (P/E) ratio of 28.00, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.
What is AZN's market cap?
AZN (AstraZeneca PLC) has a market capitalization of $288.38 billion, making it a large-cap stock.
What is AZN's price to book ratio?
Price-to-book ratio for AZN is available on our dashboard along with other valuation metrics.
Deep Dive Analysis
Explore comprehensive analysis tools to make an informed decision about AstraZeneca PLC
Full Stock Analysis
Complete AZN overview with charts and data
Is AZN Undervalued?
DCF valuation and intrinsic value analysis
Dividend Analysis
Yield, payout ratio, and dividend history
Growth Analysis
Revenue, earnings, and expansion metrics
Financial Health
Debt, liquidity, and balance sheet strength
Price Prediction
2026 forecast and price targets
Stock Forecast
12-month price forecast and analyst targets
Earnings Date
Next earnings date and historical results
Compare Before You Buy
See how AZN stacks up against its competitors
Similar Investment Decisions
Explore investment analyses for stocks similar to AstraZeneca PLC
Complete AZN Analysis
Compare AZN With
Disclaimer
This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.